200 related articles for article (PubMed ID: 36474002)
1. IL-2/GM-CSF enhances CXCR3 expression in CAR-T cells via the PI3K/AKT and ERK1/2 pathways.
Liu L; Cheng Y; Zhang F; Chen J; Tian P; Shi W; Zhou F; Yang M; Zhou M; Liu B
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5547-5557. PubMed ID: 36474002
[TBL] [Abstract][Full Text] [Related]
2. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
3. CXCR3 expression on CD34(+) hemopoietic progenitors induced by granulocyte-macrophage colony-stimulating factor: II. Signaling pathways involved.
Jinquan T; Anting L; Jacobi HH; Glue C; Jing C; Ryder LP; Madsen HO; Svejgaard A; Skov PS; Malling HJ; Poulsen LK
J Immunol; 2001 Oct; 167(8):4405-13. PubMed ID: 11591765
[TBL] [Abstract][Full Text] [Related]
4. Absorbable microparticulate cation exchanger for immunotherapeutic delivery.
Shalaby WS; Yeh H; Woo E; Corbett JT; Gray H; June CH; Shalaby SW
J Biomed Mater Res B Appl Biomater; 2004 May; 69(2):173-82. PubMed ID: 15116407
[TBL] [Abstract][Full Text] [Related]
5. Production of granulocyte-macrophage colony-stimulating factor by T cells is regulated by B7 and IL-1 beta.
Kruger M; Van Gool S; Peng XH; Coorevits L; Casteels-Van Daele M; Ceuppens JL
Immunology; 1996 May; 88(1):49-54. PubMed ID: 8707349
[TBL] [Abstract][Full Text] [Related]
6. Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice.
Li D; Li N; Zhang YF; Fu H; Feng M; Schneider D; Su L; Wu X; Zhou J; Mackay S; Kramer J; Duan Z; Yang H; Kolluri A; Hummer AM; Torres MB; Zhu H; Hall MD; Luo X; Chen J; Wang Q; Abate-Daga D; Dropulic B; Hewitt SM; Orentas RJ; Greten TF; Ho M
Gastroenterology; 2020 Jun; 158(8):2250-2265.e20. PubMed ID: 32060001
[TBL] [Abstract][Full Text] [Related]
7. CXC chemokine receptor 3 expression on CD34(+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon gamma-inducible protein 10 and monokine induced by interferon gamma.
Jinquan T; Quan S; Jacobi HH; Jing C; Millner A; Jensen B; Madsen HO; Ryder LP; Svejgaard A; Malling HJ; Skov PS; Poulsen LK
Blood; 2000 Aug; 96(4):1230-8. PubMed ID: 10942362
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release.
Oehler L; Foedinger M; Koeller M; Kollars M; Reiter E; Bohle B; Skoupy S; Fritsch G; Lechner K; Geissler K
Blood; 1997 Feb; 89(4):1147-53. PubMed ID: 9028936
[TBL] [Abstract][Full Text] [Related]
9. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.
Gargett T; Brown MP
Cytotherapy; 2015 Apr; 17(4):487-95. PubMed ID: 25573334
[TBL] [Abstract][Full Text] [Related]
10. Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Beroukas C; Stathopoulos GP; Papamichail M
Cancer; 1995 Oct; 76(7):1253-60. PubMed ID: 8630906
[TBL] [Abstract][Full Text] [Related]
11. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
[TBL] [Abstract][Full Text] [Related]
12. [Construction and function of Glypican-3-targeted fourth-generation chimeric antigen receptor T cells (secreting IL-7 and CCL19)].
Huang W; Liu Y; Hu Y; Gao J
Sheng Wu Gong Cheng Xue Bao; 2020 May; 36(5):979-991. PubMed ID: 32567281
[TBL] [Abstract][Full Text] [Related]
13. Priming effects of granulocyte-macrophage colony-stimulating factor are coupled to cholera toxin-sensitive guanine nucleotide binding protein in human T lymphocytes.
al-Aoukaty A; Giaid A; Sinoff C; Ho AD; Maghazachi AA
Blood; 1994 Mar; 83(5):1299-309. PubMed ID: 8118033
[TBL] [Abstract][Full Text] [Related]
14. GPC3-IL7-CCL19-CAR-T primes immune microenvironment reconstitution for hepatocellular carcinoma therapy.
Lu LL; Xiao SX; Lin ZY; Bai JJ; Li W; Song ZQ; Zhou YH; Lu B; Wu WZ
Cell Biol Toxicol; 2023 Dec; 39(6):3101-3119. PubMed ID: 37853185
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivo.
Bozinovski S; Jones JE; Vlahos R; Hamilton JA; Anderson GP
J Biol Chem; 2002 Nov; 277(45):42808-14. PubMed ID: 12208854
[TBL] [Abstract][Full Text] [Related]
16. GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts.
Sterner RM; Sakemura R; Cox MJ; Yang N; Khadka RH; Forsman CL; Hansen MJ; Jin F; Ayasoufi K; Hefazi M; Schick KJ; Walters DK; Ahmed O; Chappell D; Sahmoud T; Durrant C; Nevala WK; Patnaik MM; Pease LR; Hedin KE; Kay NE; Johnson AJ; Kenderian SS
Blood; 2019 Feb; 133(7):697-709. PubMed ID: 30463995
[TBL] [Abstract][Full Text] [Related]
17. Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways.
Uemura Y; Kobayashi M; Nakata H; Kubota T; Bandobashi K; Saito T; Taguchi H
Int J Mol Med; 2006 Aug; 18(2):365-73. PubMed ID: 16820947
[TBL] [Abstract][Full Text] [Related]
18. CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase.
Smit MJ; Verdijk P; van der Raaij-Helmer EM; Navis M; Hensbergen PJ; Leurs R; Tensen CP
Blood; 2003 Sep; 102(6):1959-65. PubMed ID: 12750173
[TBL] [Abstract][Full Text] [Related]
19. Third-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocol.
Tang XY; Sun Y; Zhang A; Hu GL; Cao W; Wang DH; Zhang B; Chen H
BMJ Open; 2016 Dec; 6(12):e013904. PubMed ID: 28039295
[TBL] [Abstract][Full Text] [Related]
20. Immune modulation in cancer patients after adoptive transfer of anti-CD3/anti-CD28-costimulated T cells-phase I clinical trial.
Lum LG; LeFever AV; Treisman JS; Garlie NK; Hanson JP
J Immunother; 2001; 24(5):408-19. PubMed ID: 11696696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
